# DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award

Source: https://welltoldgrants.com/grants/ht942526bcrptbccda-dow-breast-cancer-transformative-breast-cancer-consortium/  
Official notice: https://www.grants.gov/search-results-detail/362211

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make one award worth $140,000 in total. Applications closed on July 8, 2026.

| Field | Value |
|---|---|
| Opportunity number | HT942526BCRPTBCCDA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | July 8, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $140,000 |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Development Award provides successful applicants the time and resources needed to bring investigators and breast cancer consumer advocates together to establish a consortium framework and conduct preliminary research in support of an application to a future, full BCRP Transformative Breast Cancer Consortium Award (pending availability of funds). All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: · This is a development award and is a separate award mechanism from the full FY26 BCRP Transformative Breast Cancer Consortium Award (HT942526BCRPTBCCA). For FY26, investigators may be named as Consortium Director on an application submitted to either (but not both) of these award mechanisms. · Breast cancer consumer advocates must be active participants in the development and execution of the FY26 BCRP TBCCDA.

## Questions people ask

### Is HT942526BCRPTBCCDA still open?

No. It closed on July 8, 2026. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award?

Closed July 8, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $140,000 in total for one award.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.